HIGHLIGHTS
SUMMARY
The lack of sufficient high quality scientific evidence and the frequent need to prescribe off-label drugs prompted the authors to start a pharmacovigilance study, with the aim of detecting ADRs and assessing safety profiles of off-label drug prescriptions as compared to on-label drugs. April 2022 | Volume 13 | Article 837692 Safety of Off-label Drugs in Pediatric Neuropsychiatry Secondary endpoints were: to the Law 648/1996) and off-label drugs (based on the Law 94/1998). Findings are consistent with several studies (Neubert et_al, 2004; Mason et_al, 2012; Palmaro et_al, 2015) that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.